Valeant Pharmaceuticals International, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Valeant Pharmaceuticals International, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4444
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Valeant Pharmaceuticals International, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Valeant Pharmaceuticals International, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Valeant Pharmaceuticals International, Inc. (Valeant or ‘the company’) is a pharmaceutical company engaged in the development, manufacture and marketing of pharmaceutical products. The company markets a range of pharmaceutical products, medical devices and OTC products primarily in the areas of dermatology, gastrointestinal disorders, eye health and neurology. The key products of the company include contact lenses, intraocular lenses, ophthalmic surgical equipment, aesthetics devices, over-the-counter (OTC) products, gastrointestinal products, dermatological products, and Lotemax Gel. The company markets its products in the North America, Europe, the Middle East, Latin America, Asia Pacific and Africa. Valeant is headquartered in Quebec, Canada.

Scope

- Detailed information on Valeant Pharmaceuticals International, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Valeant Pharmaceuticals International, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Valeant Pharmaceuticals International, Inc. including a breakdown and examination of key business segments
- Intelligence on Valeant Pharmaceuticals International, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Valeant Pharmaceuticals International, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Valeant Pharmaceuticals International, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Valeant Pharmaceuticals International, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Valeant Pharmaceuticals International, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Valeant Pharmaceuticals International, Inc.: Company Overview 9
Valeant Pharmaceuticals International, Inc.: Overview and Key Facts 9
Valeant Pharmaceuticals International, Inc.: Overview 9
Valeant Pharmaceuticals International, Inc.: Key Facts 9
Valeant Pharmaceuticals International, Inc.: Key Employees 11
Valeant Pharmaceuticals International, Inc.: Key Employee Biographies 13
Valeant Pharmaceuticals International, Inc.: Major Products and Services 15
Valeant Pharmaceuticals International, Inc.: Company History 17
Valeant Pharmaceuticals International, Inc.: Management Statement 23
Valeant Pharmaceuticals International, Inc.: Locations and Subsidiaries 26
Valeant Pharmaceuticals International, Inc.: Key Competitors 28
Valeant Pharmaceuticals International, Inc.: Company Analysis 29
Valeant Pharmaceuticals International, Inc.: Business Description 29
Valeant Pharmaceuticals International, Inc.: SWOT Analysis 31
Valeant Pharmaceuticals International, Inc.: SWOT Overview 31
Valeant Pharmaceuticals International, Inc.: Strengths 31
Valeant Pharmaceuticals International, Inc.: Weaknesses 32
Valeant Pharmaceuticals International, Inc.: Opportunities 32
Valeant Pharmaceuticals International, Inc.: Threats 33
Valeant Pharmaceuticals International, Inc.: Corporate Financial Deals Activity 34
Valeant Pharmaceuticals International, Inc.: Financial Deals Overview 34
Valeant Pharmaceuticals International, Inc.: Targets and Partners 36
Valeant Pharmaceuticals International, Inc.: Top Deals 2014 – 2018YTD* 38
Valeant Pharmaceuticals International, Inc.: Advisors 39
Valeant Pharmaceuticals International, Inc.: Top Legal Advisors 39
Valeant Pharmaceuticals International, Inc.: Top Financial Advisors 39
Valeant Pharmaceuticals International, Inc.: Mergers and Acquisitions 40
Valeant Pharmaceuticals International, Inc.: Capital Raising 41
Valeant Pharmaceuticals International, Inc.: Partnership 42
Valeant Pharmaceuticals International, Inc.: Divestments 43
Valeant Pharmaceuticals International, Inc.: Private Equity and Ownership 44
Valeant Pharmaceuticals International, Inc.: Recent Developments 45
Valeant Pharmaceuticals International, Inc.: News and Events Summary 45
Valeant Pharmaceuticals International, Inc.: Corporate Governance 48
Valeant Pharmaceuticals International, Inc.: Financial Deals 49
Valeant Pharmaceuticals International, Inc.: Financial Performance 49
Valeant Pharmaceuticals International, Inc.: Market Developments 50
Valeant Pharmaceuticals International, Inc.: Regulatory and Legal Events 52
Appendix 54
Contact Us 54
Methodology 54
About MarketLine 55

List of Tables
Table 1: Valeant Pharmaceuticals International, Inc.: Key Facts
Table 2: Valeant Pharmaceuticals International, Inc.: Key Employees
Table 3: Valeant Pharmaceuticals International, Inc.: Locations and Subsidiaries
Table 4: Valeant Pharmaceuticals International, Inc.: Key Competitors
Table 5: Valeant Pharmaceuticals International, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Valeant Pharmaceuticals International, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Valeant Pharmaceuticals International, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Valeant Pharmaceuticals International, Inc.: Targets and Partners
Table 9: Valeant Pharmaceuticals International, Inc.: Top Deals 2014 - 2018YTD*
Table 10: Valeant Pharmaceuticals International, Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Valeant Pharmaceuticals International, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Valeant Pharmaceuticals International, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Valeant Pharmaceuticals International, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Valeant Pharmaceuticals International, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 15: Valeant Pharmaceuticals International, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 16: Valeant Pharmaceuticals International, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 17: Valeant Pharmaceuticals International, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 18: Valeant Pharmaceuticals International, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 19: Valeant Pharmaceuticals International, Inc.: Divestments by Geography (2014 - YTD*2018)
Table 20: Valeant Pharmaceuticals International, Inc.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 21: Valeant Pharmaceuticals International, Inc.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 22: Valeant Pharmaceuticals International, Inc.: News and Events Summary
Table 23: Valeant Pharmaceuticals International, Inc.: Corporate Governance
Table 24: Valeant Pharmaceuticals International, Inc.: Financial Deals
Table 25: Valeant Pharmaceuticals International, Inc.: Financial Performance
Table 26: Valeant Pharmaceuticals International, Inc.: Market Developments
Table 27: Valeant Pharmaceuticals International, Inc.: Regulatory and Legal Events

List of Figures
Figure 1: Valeant Pharmaceuticals International, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Valeant Pharmaceuticals International, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Valeant Pharmaceuticals International, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Valeant Pharmaceuticals International, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Valeant Pharmaceuticals International, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Valeant Pharmaceuticals International, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 7: Valeant Pharmaceuticals International, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 8: Valeant Pharmaceuticals International, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 9: Valeant Pharmaceuticals International, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 10: Valeant Pharmaceuticals International, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 11: Valeant Pharmaceuticals International, Inc.: Divestments by Geography (2014 - YTD*2018)
Figure 12: Valeant Pharmaceuticals International, Inc.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 13: Valeant Pharmaceuticals International, Inc.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Valeant Pharmaceuticals International, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • University of California San Diego-医療機器分野:企業M&A・提携分析
    Summary University of California San Diego (UCSD), a subsidiary of University of California, is a public research university that offers education and research with a portfolio of undergraduate, graduate, postdoctoral and professional schools. It offers courses in various fields including arts and h …
  • Eesti Energia AS:企業の戦略・SWOT・財務分析
    Eesti Energia AS - Strategy, SWOT and Corporate Finance Report Summary Eesti Energia AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Dentsu, Inc.:企業の戦略・SWOT・財務分析
    Dentsu, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dentsu, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • ContraFect Corp (CFRX):企業の財務・戦略的SWOT分析
    Summary ContraFect Corp (ContraFect) is a clinical stage biotechnology company that discovers and develops therapeutic protein and antibody products. The company develops products using lysin and monoclonal antibody platforms for the treatment of life threatening, drug-resistant infectious diseases. …
  • Baxter International Inc.:企業のM&A・事業提携・投資動向
    Baxter International Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Baxter International Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Nynas AB:企業の戦略的SWOT分析
    Nynas AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Therapeutic Solutions International Inc (TSOI):製薬・医療:M&Aディール及び事業提携情報
    Summary Therapeutic Solutions International Inc (Therapeutic Solutions) is a pharmaceutical company that offers supplements. The company offers products such as DermalStilbene, NanoStilbene and ProJuvenol. Its ProJuvenol consists of anti-aging ingredients which helps for a healthy functionality for …
  • BP Plc:企業のM&A・事業提携・投資動向
    BP Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BP Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital rais …
  • Neovacs SA (ALNEV):製薬・医療:M&Aディール及び事業提携情報
    Summary Neovacs SA (Neovacs) is a biotechnology company that develops various therapeutic vaccines for the treatment of autoimmune disorders, inflammatory diseases and cancers. The company offers TNF- kinoid and IFNalpha- kinoid products used for the treatment of rheumatoid arthritis, Crohn’s diseas …
  • UniQuest Pty Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary UniQuest Pty Ltd (UniQuest), a subsidiary of The University of Queensland is a commercialization company that offers consultancy services. The company commercializes intellectual property and research outcomes of University of Queensland. It offers services such as eShop, witness, contract r …
  • Salvatore Ferragamo SpA (SFER):企業の財務・戦略的SWOT分析
    Salvatore Ferragamo SpA (SFER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Achaogen Inc (AKAO)-製薬・医療分野:企業M&A・提携分析
    Summary Achaogen Inc (Achaogen) is a biopharmaceutical company that discovers, develops and commercializes novel anti bacterials for the treatment of multi-drug resistant and gram-negative infections. The company is developing plazomicin for the treatment of serious bacterial infections due to MDR E …
  • Hansgrohe SE:企業の戦略・SWOT・財務情報
    Hansgrohe SE - Strategy, SWOT and Corporate Finance Report Summary Hansgrohe SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • NuVasive Inc (NUVA):製品パイプライン分析
    Summary NuVasive Inc (NuVasive) is a medical device company that provides minimally invasive, procedurally-integrated spine solutions. The company principally provides Maximum Access Surgery (MAS), a minimally-disruptive surgical platform. MAS platform enables surgeons to perform a range of minimall …
  • Ctrip.Com International Ltd:企業の戦略・SWOT・財務分析
    Ctrip.Com International Ltd - Strategy, SWOT and Corporate Finance Report Summary Ctrip.Com International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Helvetia Group:企業の戦略・SWOT・財務情報
    Helvetia Group - Strategy, SWOT and Corporate Finance Report Summary Helvetia Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Ujaas Energy Ltd (UJAAS):企業の財務・戦略的SWOT分析
    Summary Ujaas Energy Ltd (Ujaas) is a renewable energy company that offers solar energy development products and services. The company provides products such as home products, park products, transformers, and others. It offers transformers products such as power transformer, convertor transformers, …
  • Corium International Inc (CORI):製薬・医療:M&Aディール及び事業提携情報
    Summary Corium International Inc (Corium) is a commercial-stage biopharmaceutical company that produces and develops central nervous system pharmaceutical products. The company develops transdermal healthcare products with the help of Corplex technology platform using small molecules. Its products i …
  • Fulcrum Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Fulcrum Therapeutics Inc (Fulcrum Therapeutics) is a drug development company that focuses on the discovery and development of small molecule therapies to unlock the gene regulation in disease. The company’s pipeline products include Fragile X syndrome, Facioscapulohumeral muscular dystrophy …
  • Hydro One Ltd (H):企業の財務・戦略的SWOT分析
    Hydro One Ltd (H) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆